Professor Philip Johnson MD, FRCP

Professor in Translational Oncology Molecular & Clinical Cancer Medicine

    Research

    Hepatobiliary cancer

    I am interested in clinical and laboratory aspects of hepatobiliary and pancreatic cancer with a specific interest in the use of serological biomarkers for diagnosis and prognosis

    Research Group Membership

    Research Grants

    Validation of serum biomarkers for pancreatic cancer detection

    NORTH WEST CANCER RESEARCH INCORPORATING CLATTERBRIDGE CANCER RESEARCH - NWCR (UK)

    October 2013 - June 2016

    A prospective evaluation of a serological screening test for hepatocellular carcinoma; comparison with current standard of care

    LIVERPOOL HEALTH PARTNERS (UK)

    February 2013 - April 2016